- A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus
-
Yang SJ, Min KW, Gupta SK, Park JY, K.Shivane V, Agarwal PK, Kim DM, Kim YE, Baik SH
- KMID: 2518902
- Diabetes Metab J.
- 2021 Jul;45(4):606-612.
- doi: 10.4093/dmj.2020.0047
The purpose of this extension study was to assess the long-term efficacy and safety of gemigliptin 50 mg in patients with type 2 diabetes mellitus (T2DM). Patients with T2DM who... -
- CITED
-
- Close
- SHARE
-
- Close
